Adenocarcinoma — Research

Adenocarcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	490,877	`("Adenocarcinoma"[mh] OR "Adenocarcinomas"[mh] OR "Adenoma, Malignant"[mh] OR "Adenomas, Malignant"[mh])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	93,894	`("Adenocarcinoma"[mh] OR "Adenocarcinomas"[mh] OR "Adenoma, Malignant"[mh] OR "Adenomas, Malignant"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	15,455	`("Adenocarcinoma"[mh] OR "Adenocarcinomas"[mh] OR "Adenoma, Malignant"[mh] OR "Adenomas, Malignant"[mh]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 20 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (378)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 151–175 of 378 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics.
· Mol Cancer Ther · 2013 · PMID 23371856 · validated civic_curation pubmed
Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancer.
· Sci Transl Med · 2013 · PMID 24353160 · validated civic_curation pubmed
Successful treatment with weekly high-dose erlotinib against meningeal metastases from epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma.
· Respir Investig · 2016 · PMID 27566387 · validated civic_curation pubmed
EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.